Statements (75)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:physicist
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:amoxicillin
gptkb:Streptococci gptkb:Synflorix gptkb:Mc_Carty-Mac_Leod-Mc_Carty_experiment |
| gptkbp:analyzes |
sepsis
|
| gptkbp:can_lead_to |
meningitis
|
| gptkbp:caused_by |
gptkb:healthcare_organization
respiratory infections vaccine-preventable diseases otitis media ear infections lung infections bacteremia pneumococcal disease bacterial meningitis severe pneumonia in adults |
| gptkbp:common_name |
long-term care facilities
|
| gptkbp:communication |
respiratory droplets
|
| gptkbp:complications |
gptkb:virus
diabetic patients |
| gptkbp:cultural_practices |
sputum samples
|
| gptkbp:disease_resistance |
children and elderly
|
| gptkbp:family |
gptkb:Streptococcaceae
|
| gptkbp:first_described_by |
1881
|
| gptkbp:focuses_on |
public health initiatives
global health initiatives infectious disease research clinical guidelines for treatment antibiotic resistance monitoring programs infectious disease prevention efforts |
| gptkbp:founded |
antibiotic stewardship programs
|
| gptkbp:genetic_diversity |
over 90
clinical microbiology labs |
| gptkbp:has_role |
chronic obstructive pulmonary disease (COPD) exacerbations
|
| https://www.w3.org/2000/01/rdf-schema#label |
Streptococcus pneumoniae
|
| gptkbp:is_affected_by |
pneumococcal infections
|
| gptkbp:is_associated_with |
sinusitis
high rates of hospitalization |
| gptkbp:is_characterized_by |
alpha-hemolysis
|
| gptkbp:is_critical_for |
pediatric healthcare.
|
| gptkbp:is_found_in |
human nasopharynx
|
| gptkbp:is_involved_in |
community-acquired pneumonia
pediatric infections |
| gptkbp:is_known_for |
capsule formation
pneumococcus |
| gptkbp:is_linked_to |
chronic diseases
high morbidity and mortality |
| gptkbp:is_part_of |
normal flora
|
| gptkbp:is_protected_by |
vaccination
|
| gptkbp:is_recognized_by |
immune system
lancefield classification |
| gptkbp:is_studied_in |
microbiology
virulence factors |
| gptkbp:is_vulnerable_to |
certain antibiotics
immunocompromised patients |
| gptkbp:issues |
public health authorities
|
| gptkbp:notable_production |
pneumolysin
|
| gptkbp:notable_recipients |
hospital-acquired infections
pneumonia-related deaths |
| gptkbp:passes_through |
host immune responses
|
| gptkbp:research |
antimicrobial resistance
chronic respiratory conditions |
| gptkbp:research_focus |
vaccine development strategies
|
| gptkbp:scientific_classification |
Lactobacillales
|
| gptkbp:sensor |
gptkb:penicillin
|
| gptkbp:social_responsibility |
culture and sensitivity tests
|
| gptkbp:subject |
vaccine development
clinical trials for new treatments vaccine efficacy studies |
| gptkbp:targets |
antibiotic therapy
|
| gptkbp:treatment |
antibiotics
|
| gptkbp:type_of |
Gram-positive bacteria
|
| gptkbp:was_a_factor_in |
respiratory disease outbreaks
|